Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-40.79	-113.36	-80.52
Graham Fair Price	37.45	5.03	3.66
PEG	-68.29	0.13	-0.40
Price/Book	6.27	2.18	2.05
Price/Cash Flow	57.72	-66.91	-158.26
Prices/Earnings	-47.77	12.58	24.10
Price/Sales	-45.78	7.04	12.98
Price/FCF	57.72	-66.91	-158.26
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-59.93	0.14	0.34
ROA	106.35	< 0.005	< 0.005
ROE	0.02	0.04	103.48
ROIC	0.03	0.02	-26.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.68	-0.32	112.20
Dividends QOQ	-0.38	-0.24	35.22
EBIT QOQ	0.07	-0.04	-42.50
EPS QOQ	-0.61	1.00	64.71
FCF QOQ	-1.16	-2.06	-77.88
Revenue QOQ	-0.59	1.39	135.71
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.18	0.23	29.00
Quick Ratio	17.03	0.07	-99.56
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.29	5.10	-3.64
Cash	1.41	3.04	115.41
Capex	< 0.005	< 0.005	-93.88
Free Cash Flow	-0.07	-0.17	-142.21
Revenue	0.83	1.58	88.87
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	17.03	0.10	-99.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.83	-1.96	7.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating